|
|
|
|
|
|
|
|
Response to: “[Miller’s] Response to: ‘Beyond the mammography debate: a moderate perspective’” | Yaffe | Current Oncology
......Mammography screening has limitations. They include reduced sensitivity in some women, including those with very dense breasts, recalls of some women without cancer for further imaging and, occasionally, needle biopsy. Certainly, some screen-detected breast cancers, mainly ductal carcinoma in situ (and probably some self-detected cancers) are overtreated. But to assert that screening does not reduce breast cancer deaths—not to mention allow for less use of some of the debilitating, aggressive therapies necessary for women with advanced disease—is a fringe opinion at odds with the evidence and global expert opinion. Furthermore, it is an irresponsible message to convey to women and their health care providers.Author Affiliations
Imaging Research, Sunnybrook Research Institute, Departments of
Medical Biophysics and Medical Imaging, University of Toronto, Smarter
Imaging Program, Ontario Institute for Cancer Research, Toronto,
Ontario.
REFERENCES
1. Lauby-Secretan B,
Scoccianti C, Loomis D, et al. on behalf of the International Agency for
Research on Cancer Handbook Working Group. Breast-cancer
screening—viewpoint of the iarc working group. N Engl J Med 2015;372:2353–8.
2. Independent U.K.
Panel on Breast Cancer Screening. The benefits and harms of breast
cancer screening: an independent review. Lancet 2012;380:1778–86.
3. Narod SA. Counterpoint re: “Mammography screening-sticking to the science.” Curr Oncol 2015;22:177.
4. Boyd NF, Jong RA,
Yaffe MJ, Tritchler D, Lockwood G, Zylak CJ. A critical appraisal of the
Canadian National Breast Cancer Screening Study. Radiology
1993;189:661–3.
5. Baines CJ, Miller
AB, Kopans DB, et al. Canadian National Breast Screening Study:
assessment of technical quality by external review. AJR Am J Roentgenol
1990;155:743–7.
6. Baum M, Demicheli
R, Hrushesky W, Retsky M. Does surgery unfavourably perturb the “natural
history” of early breast cancer by accelerating the appearance of
distant metastases? Eur J Cancer 2005;41:508–15.
9. Miller AB, Baines
CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast
cancer detection and death rates among women aged 40 to 49 years. CMAJ
1992;147:1459–76. [Erratum in: CMAJ 1993;148:718]
11. Miller AB, Wall
C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for
breast cancer incidence and mortality of the Canadian National Breast
Screening Study: randomised screening trial. BMJ 2014;348:g366.
Correspondence to: Martin J. Yaffe, Sunnybrook Health Sciences Centre, 2075
Current Oncology, VOLUME 23, NUMBER 3, June 2016
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.